Foss, Stian
Sakya, Siri A. http://orcid.org/0000-0002-5893-6771
Aguinagalde, Leire
Lustig, Marta
Shaughnessy, Jutamas http://orcid.org/0000-0003-0832-9954
Cruz, Ana Rita
Scheepmaker, Lisette
Mathiesen, Line http://orcid.org/0000-0002-3210-159X
Ruso-Julve, Fulgencio http://orcid.org/0000-0001-6500-6807
Anthi, Aina Karen http://orcid.org/0000-0002-1725-4571
Gjølberg, Torleif Tollefsrud http://orcid.org/0000-0002-1719-7677
Mester, Simone
Bern, Malin
Evers, Mitchell
Bratlie, Diane B.
Michaelsen, Terje E.
Schlothauer, Tilman
Sok, Devin
Bhattacharya, Jayanta
Leusen, Jeanette
Valerius, Thomas http://orcid.org/0000-0001-9181-8067
Ram, Sanjay http://orcid.org/0000-0003-0058-9532
Rooijakkers, Suzan H. M. http://orcid.org/0000-0003-4102-0377
Sandlie, Inger
Andersen, Jan Terje http://orcid.org/0000-0003-1710-1628
Article History
Received: 7 April 2023
Accepted: 22 February 2024
First Online: 7 March 2024
Competing interests
: J.T.A., I.S. and S.F. are inventors of the invention claimed in a patent family arising from WO2017158426 and WO2019057564 with the title “Engineered immunoglobulins with altered FcRn binding”. The remaining authors declare no competing interests.